glp 1 neck mass GLP-1 receptor agonists in the context of cancer: the road ahead Brown Adipose Tissue Mimicking Head

In a Mayo Clinic study presented at an annual meeting of the Endocrine Society in July 2025, researchers found that, over 18 months, 40 postmenopausal women who combined the GLP-1 drug tirzepatide (used in Mounjaro and Zepbound) with hormone therapy lost an average of 17 percent of their body weight

Am J Physiol Endocrinol Metab 304(1):E1-13

These titration schedules are evidence-based and designed to minimise gastrointestinal adverse effectsthe most common side effects of this drug class

doi: 10.2196/62667

Besides this, increasing awareness of the advantages of these drugs through marketing efforts and direct-to-consumer advertising, particularly on social media, and a favorable regulatory landscape are enabling approvals and boosting demand in the market